# Adapti, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Adapti, Inc.). ## Overview Adapti, Inc. is a U.S.-based early-stage services company that has built an AI-driven software platform to analyze product data, social media signals, and audience behavior to identify the most effective influencers for a given product or brand. The company developed the Adapti platform internally beginning in 2021 and has used third-party AI tools such as ChatGPT, OpenAI, and Google AI to create a "data fingerprint" for products and companies. Management says the platform is intended to improve return on marketing spend by matching products with influencers and curated audiences, and it has been tested in live transactions supporting sales of Dermacia products. In addition to the AI platform, the company has sold licensed consumer products direct-to-consumer and has taken on outsourced programming work to generate limited income while deploying its technical staff. ## Products & services • Adapti AI influencer-matching platform • Social media scraping and audience analytics • Product and company data fingerprinting • Direct-to-consumer Dermacia skin care products • Outsourced software/programming services • Campaign analytics and promotion optimization - **AI marketing platform** (0%) — Software that analyzes product, company, and social data to identify influencers and optimize campaign ROI. - **Consumer products** (100%) — Licensed Dermacia skin care and healthcare products sold direct to consumers. - **Outsourced services** (0%) — Programming and related outsourced work performed to generate limited service income. - Adapti AI influencer-matching platform - Social media scraping and audience analytics - Product and company data fingerprinting - Direct-to-consumer Dermacia skin care products - Outsourced software/programming services - Campaign analytics and promotion optimization ## Customers Adapti's intended customer base includes brands and product owners that want to use influencer marketing and social media promotion more efficiently. The company also appears to support its own Dermacia product sales, which implies direct consumers are a current customer group for the licensed product line. Management specifically references Ballengee clients as a future use case for the platform, suggesting sports, entertainment, and talent-related clients are an important target segment. Because the platform is designed to improve ROI on promotional spend, customers are likely buying either campaign execution support or analytics that help them choose the right influencers and channels. - **Brand and product marketing clients** (primary) — Buy influencer selection and campaign analytics to improve social media promotion efficiency and ROI. - **Dermacia direct consumers** (primary) — Buy licensed skin care and healthcare products sold directly by the company. - **Ballengee client base** (secondary) — Uses the platform and related services for social media opportunities and audience engagement. - **Outsourced services customers** (emerging) — Buy programming or project-based technical work while the platform is still early-stage. - Brands and product owners seeking better influencer marketing ROI - Dermacia direct-to-consumer buyers of skin care and healthcare products - Ballengee clients needing social media promotion support - Entertainment, sports, and talent-related clients using audience reach - Marketing teams that want campaign analytics and audience targeting ## Geography Adapti is headquartered in the United States and the available disclosures do not provide a country-by-country revenue split. The business appears to be primarily U.S.-oriented, given its SEC reporting, U.S. consumer product sales, and references to U.S. AI regulation and social media platforms. Its platform depends on third-party AI tools and cloud infrastructure, which can create cross-border technology and compliance exposure even if end customers are domestic. The company also faces regulatory developments in the United States, the European Union, and other jurisdictions because its product relies on AI and data collection. - Headquartered in the United States - Primary operating and reporting base is U.S.-centric - Dermacia direct-to-consumer sales appear to be U.S. focused - AI and data processing may involve third-party cloud and AI providers - Regulatory exposure extends beyond the U.S. to the EU and other jurisdictions ## Strategy The company's core strategy is to turn the internally developed Adapti platform into a commercial tool for influencer selection, campaign optimization, and social-media-driven sales. Management is trying to leverage the platform across its own Dermacia product sales and, potentially, Ballengee client relationships to demonstrate practical use cases and build a monetizable data asset. A second strategic priority is to use the company's programming capabilities to take on outsourced work and keep personnel deployed while the platform matures. Longer term, the company is attempting to build a differentiated AI marketing capability, but success depends on proving that the platform can generate measurable ROI and attract repeat customers. - **Commercialize Adapti through live client use** (short-term) — The platform has not yet generated revenue, so proving commercial demand is essential to turning development spend into a business. - **Leverage internal and proprietary data to improve targeting** (medium-term) — Better data and feedback loops should improve influencer matching and campaign ROI, which is the platform's core value proposition. - **Expand monetization beyond a single product line** (medium-term) — Dependence on Dermacia limits scale, so broader client adoption is needed for the platform to matter economically. - Commercialize the Adapti platform beyond internal testing - Use the platform to support Dermacia sales and prove ROI - Extend the platform to Ballengee clients and related social media use cases - Monetize accumulated campaign and public data to refine the algorithm - Use outsourced programming work to generate interim revenue - Build a defensible AI-driven influencer selection capability ## Risks Adapti is an early-stage company with limited operating history, so investors have little evidence that the platform can become a durable revenue engine. The business depends on consumer tastes, social media trends, and the popularity of the talent or brands it represents, which makes demand volatile and hard to forecast. Because the platform relies on AI, social data, and cloud infrastructure, it faces cybersecurity, data-loss, intellectual property, and regulatory risks that could raise costs or interrupt operations. Reputation risk is also important because adverse publicity around management, clients, or partners could damage relationships and reduce the company's ability to win new business. The company also appears to have concentration risk around a small number of products, clients, and strategic relationships, which increases execution risk if any one initiative underperforms. - **Limited operating history and unproven monetization** [high] — The company has spent on development but has not yet generated revenue from Adapti, so the platform's commercial success remains uncertain. - **AI regulatory and legal risk** [high] — Governments in the U.S., EU, and elsewhere are considering or adopting AI rules that could impose compliance burdens or limit certain uses. - **Cybersecurity and data protection risk** [high] — The platform processes proprietary, confidential, and personal data and depends on third-party hosting and cloud providers. - **Consumer preference and brand reputation risk** [medium] — Demand for services and content is sensitive to changing tastes and publicity around the company or its partners. - **Intellectual property and competitive technology risk** [medium] — Competitors with greater resources may build better tools, and some platform elements may not be fully protectable. - Limited operating history makes it hard to judge the platform's commercial viability - Revenue depends on changing consumer tastes and social media trends - AI regulation could increase compliance costs or restrict product use - Cybersecurity breaches could disrupt operations and expose sensitive data - Third-party AI and cloud dependencies create service and security risk - Reputation damage could reduce client retention and new business wins - Concentration in Dermacia and a small set of relationships increases execution risk ## Accounting The most important accounting issue is that the company has capitalized and expensed meaningful internal development effort around the Adapti platform, so investors should watch how software development costs are treated and whether any future impairment or recoverability issues arise. Revenue recognition is also important because the company has not yet generated revenue from Adapti, and any future contracts may involve a mix of software, services, and product sales with different timing rules. The Dermacia direct-to-consumer business may create quarter-to-quarter volatility in revenue and margins, especially if sales are promotional or tied to campaign timing. As a smaller reporting company, the company may provide less extensive disclosure than larger peers, which makes estimates and management judgment more important when evaluating reported results. Because the business relies on third-party AI, cloud, and outsourced services, investors should also monitor contingent liabilities, vendor commitments, and any costs associated with cybersecurity or regulatory compliance. - **Software development cost treatment** — Could materially affect operating loss and balance sheet presentation - **Revenue recognition for mixed offerings** — Affects timing of revenue and gross margin - **Impairment of capitalized intangibles** — Could create non-cash charges and reduce equity - **Quarterly volatility in consumer product sales** — Makes quarterly comparisons less stable - Internal software development costs may affect expense timing and asset recognition - Future Adapti contracts may combine software and services with different revenue timing - Dermacia product sales can create seasonal or campaign-driven revenue swings - Impairment risk may arise if capitalized development does not generate expected cash flows - Smaller reporting company status can limit disclosure detail and comparability - Third-party AI and cloud dependencies may create contingent costs and vendor commitments --- *Last updated: 2026-08-11T04:46:19.470530+00:00*